A detailed history of Bayforest Capital LTD transactions in Natera, Inc. stock. As of the latest transaction made, Bayforest Capital LTD holds 2,643 shares of NTRA stock, worth $369,808. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,643
Previous 1,353 95.34%
Holding current value
$369,808
Previous $214 Million 31.14%
% of portfolio
0.12%
Previous 0.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025

BUY
$132.63 - $177.0 $171,092 - $228,330
1,290 Added 95.34%
2,643 $147 Million
Q4 2024

Feb 14, 2025

BUY
$117.67 - $174.0 $159,207 - $235,422
1,353 New
1,353 $214 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $13.6B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Bayforest Capital LTD Portfolio

Follow Bayforest Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayforest Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bayforest Capital LTD with notifications on news.